Tech Company Financing Transactions

Genome Medical Funding Round

On 1/6/2018, Genome Medical landed $23 million in Series A funding from Canaan Partners, GE Ventures and Illumina Ventures.

Transaction Overview

Company Name
Genome Medical
Announced On
1/6/2018
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series A
Investors

Canaan Partners (Lead Investor)

GE Ventures (Lead Investor) (Iana Dimkova)

Illumina Ventures

Kaiser Permanente Ventures (Amy Raimundo)

Proceeds Purpose
In addition, the investment by strategic partners will support Genome Medical's goal to extend its services to hospitals, health systems, large physician groups and employer groups.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
701 Gateway Blvd. 380
San Francisco, CA 94080
USA
Phone
(877) 688-0992
Website
www.genomemedical.com
Email Address
[email protected]
Overview
We founded Genome Medical to bridge the growing gap between available genome technology and current medical practice. In an age of incredible medical achievements and the advancement of DNA sequencing, many physicians, patients, and healthy individuals lack access to the advantages of genetic testing.
Profile
Genome Medical LinkedIn Company Profile
Social Media
Genome Medical Company Twitter Account
Company News
Genome Medical News
Facebook
Genome Medical on Facebook
YouTube
Genome Medical on YouTube

Management Team

Title
Name
Email & Social
Chairman
Randy Scott
  Randy Scott LinkedIn Profile  Randy Scott Twitter Account  Randy Scott News  Randy Scott on Facebook
Chief Executive Officer
Lisa Alderson
  Lisa Alderson LinkedIn Profile  Lisa Alderson Twitter Account  Lisa Alderson News  Lisa Alderson on Facebook
Chief Medical Officer
Steven Bleyl
  Steven Bleyl LinkedIn Profile  Steven Bleyl Twitter Account  Steven Bleyl News  Steven Bleyl on Facebook
Chief Operating Officer
Kristin Ashcraft
  Kristin Ashcraft LinkedIn Profile  Kristin Ashcraft Twitter Account  Kristin Ashcraft News  Kristin Ashcraft on Facebook
Chief Scientific Officer
Hunt Willard
  Hunt Willard LinkedIn Profile  Hunt Willard Twitter Account  Hunt Willard News  Hunt Willard on Facebook
Co-Founder
Robert Green
  Robert Green LinkedIn Profile  Robert Green Twitter Account  Robert Green News  Robert Green on Facebook
Vice President
Erica Ramos
  Erica Ramos LinkedIn Profile  Erica Ramos Twitter Account  Erica Ramos News  Erica Ramos on Facebook
Vice President
Lisa Weingartner
  Lisa Weingartner LinkedIn Profile  Lisa Weingartner Twitter Account  Lisa Weingartner News  Lisa Weingartner on Facebook
VP - Bus. Development
Amy McLaughlin
  Amy McLaughlin LinkedIn Profile  Amy McLaughlin Twitter Account  Amy McLaughlin News  Amy McLaughlin on Facebook
VP - Engineering
Vineet Kumar
  Vineet Kumar LinkedIn Profile  Vineet Kumar Twitter Account  Vineet Kumar News  Vineet Kumar on Facebook
VP - General Counsel
Minh Merchant
  Minh Merchant LinkedIn Profile  Minh Merchant Twitter Account  Minh Merchant News  Minh Merchant on Facebook
VP - Marketing
William Taggart
  William Taggart LinkedIn Profile  William Taggart Twitter Account  William Taggart News  William Taggart on Facebook
VP - Sales
Angie Inlow
  Angie Inlow LinkedIn Profile  Angie Inlow Twitter Account  Angie Inlow News  Angie Inlow on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/6/2018: KBP Biosciences venture capital transaction
Next: 1/6/2018: Gossamer Bio venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.